SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Vontobel Holding Ltd.

Vontobel Holding Ltd. lessened its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 31.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 21,277 shares of the exchange traded fund’s stock after selling 9,554 shares during the period. Vontobel Holding Ltd.’s holdings in SPDR S&P Biotech ETF were worth $1,900,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. JPMorgan Chase & Co. grew its position in SPDR S&P Biotech ETF by 179.1% in the first quarter. JPMorgan Chase & Co. now owns 7,534,471 shares of the exchange traded fund’s stock worth $574,202,000 after buying an additional 4,835,071 shares during the last quarter. Jane Street Group LLC grew its holdings in shares of SPDR S&P Biotech ETF by 111.4% in the 2nd quarter. Jane Street Group LLC now owns 172,730 shares of the exchange traded fund’s stock worth $12,829,000 after acquiring an additional 1,682,382 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. acquired a new stake in shares of SPDR S&P Biotech ETF during the third quarter worth $102,900,000. Healthcare of Ontario Pension Plan Trust Fund raised its position in shares of SPDR S&P Biotech ETF by 103.3% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,771,000 shares of the exchange traded fund’s stock worth $129,318,000 after purchasing an additional 900,000 shares during the period. Finally, Squarepoint Ops LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the first quarter valued at $34,666,000.

SPDR S&P Biotech ETF Trading Down 0.8 %

Shares of XBI opened at $82.81 on Friday. The business’s 50-day moving average price is $93.52 and its 200 day moving average price is $84.21. The stock has a market capitalization of $6.43 billion, a P/E ratio of 11.47 and a beta of 1.08. SPDR S&P Biotech ETF has a 1-year low of $63.80 and a 1-year high of $103.52.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.